Panelists discuss how the current treatment landscape for chronic graft-versus-host disease includes a range of immunosuppressive approaches, from traditional corticosteroids and calcineurin ...

Panelists discuss how physician assistants educate and empower chronic graft-versus-host disease patients and their caregivers to recognize, report, and manage symptoms effectively, detailing ...

“We [as oncology nurses] end up establishing good rapports with our patients, and we’re basically the frontlines to nutritional deficiencies,” DiRubbo said. “So assessing nutritional needs from the ...

Oncology nurses and APPs play a role in supporting caregivers while the patient they care for receives a diagnosis and cancer ...

Oncology nurses should inform patients about adverse events and the signs of interstitial lung disease before treating their breast cancer with T-DXd.

Belantamab plus VRd led to promising outcomes in newly diagnosed transplant-eligible myeloma, study results showed.

The agency approved selpercatinib for the treatment of patients with advanced or metastatic, RET-mutant medullary thyroid cancer. The FDA approved selpercatinib (Retevmo) for the treatment of adult ...

An oncology research nurse balances patient care with rigorous data collection, emphasizing communication and collaboration to advance cancer research. Oncology research nurses play an integral role ...

Chlorhexidine dressings, along with proper patient education, are key in preventing central line-associated blood stream infections in patients with cancer.

Early Switch to Atezolizumab After Vemurafenib/Cobimetinib Run-in Shows Improved Survival Trend in Melanoma ...

The FDA approved osimertinib for locally advanced, unresectable stage III EGFR-mutated non-small cell lung cancer. The FDA approved osimertinib (Tagrisso) for the treatment of adults with locally ...